Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study

M. Attauabi; J. F. Dahlerup; A. Poulsen; M. Rosager Hansen; M. K. Vester-Andersen; S. Eraslan; A. P. Prahm; N. Pedersen; L. Larsen; T. Jess; A. Neumann; K. V. Haderslev; A. Molazahi; A. B. Lødrup; H. Glerup; A. M. Oppfeldt; M. D. Jensen; K. Theede; M. Kiszka-Kanowitz; J. B. Seidelin; J. Burisch; the Danish COVID-IBD Study Group

doi:10.1093/ecco-jcc/jjab232.807

Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study

M. Attauabi, J. F. Dahlerup, A. Poulsen, M. Rosager Hansen, M. K. Vester-Andersen, S. Eraslan, A. P. Prahm, N. Pedersen, L. Larsen, T. Jess, A. Neumann, K. V. Haderslev, A. Molazahi, A. B. Lødrup, H. Glerup, A. M. Oppfeldt, M. D. Jensen, K. Theede, M. Kiszka-Kanowitz, J. B. SeidelinJ. Burisch, the Danish COVID-IBD Study Group

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Journal of Crohn's & colitis
Volume	16
Issue number	Suppl. 1
Pages (from-to)	I587-I588
ISSN	1873-9946
DOIs	https://doi.org/10.1093/ecco-jcc/jjab232.807
Publication status	Published - Jan 2022
Event	17th Congress of ECCO - Virtual Duration: 16 Feb 2022 → 19 Feb 2022 Conference number: 17

Conference

Conference	17th Congress of ECCO
Number	17
Location	Virtual
Period	16/02/2022 → 19/02/2022

Bibliographical note

Abstract No. P686

Access to Document

10.1093/ecco-jcc/jjab232.807

Cite this

Attauabi, M., Dahlerup, J. F., Poulsen, A., Hansen, M. R., Vester-Andersen, M. K., Eraslan, S., Prahm, A. P., Pedersen, N., Larsen, L., Jess, T., Neumann, A., Haderslev, K. V., Molazahi, A., Lødrup, A. B., Glerup, H., Oppfeldt, A. M., Jensen, M. D., Theede, K., Kiszka-Kanowitz, M., ... the Danish COVID-IBD Study Group (2022). Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study. Journal of Crohn's & colitis, 16(Suppl. 1), I587-I588. https://doi.org/10.1093/ecco-jcc/jjab232.807

@article{512981b74e224ad0b488edfd78408659,

title = "Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study",

author = "M. Attauabi and Dahlerup, {J. F.} and A. Poulsen and Hansen, {M. Rosager} and Vester-Andersen, {M. K.} and S. Eraslan and Prahm, {A. P.} and N. Pedersen and L. Larsen and T. Jess and A. Neumann and Haderslev, {K. V.} and A. Molazahi and L{\o}drup, {A. B.} and H. Glerup and Oppfeldt, {A. M.} and Jensen, {M. D.} and K. Theede and M. Kiszka-Kanowitz and Seidelin, {J. B.} and J. Burisch and {the Danish COVID-IBD Study Group}",

note = "Abstract No. P686; null ; Conference date: 16-02-2022 Through 19-02-2022",

year = "2022",

month = jan,

doi = "10.1093/ecco-jcc/jjab232.807",

language = "English",

volume = "16",

pages = "I587--I588",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "Suppl. 1",

}

Attauabi, M, Dahlerup, JF, Poulsen, A, Hansen, MR, Vester-Andersen, MK, Eraslan, S, Prahm, AP, Pedersen, N, Larsen, L , Jess, T, Neumann, A, Haderslev, KV, Molazahi, A, Lødrup, AB, Glerup, H, Oppfeldt, AM, Jensen, MD, Theede, K, Kiszka-Kanowitz, M, Seidelin, JB, Burisch, J & the Danish COVID-IBD Study Group 2022, 'Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study', Journal of Crohn's & colitis, vol. 16, no. Suppl. 1, pp. I587-I588. https://doi.org/10.1093/ecco-jcc/jjab232.807

Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study. / Attauabi, M.; Dahlerup, J. F.; Poulsen, A. et al.

In: Journal of Crohn's & colitis, Vol. 16, No. Suppl. 1, 01.2022, p. I587-I588.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications- A Danish prospective population-based cohort study

AU - Attauabi, M.

AU - Dahlerup, J. F.

AU - Poulsen, A.

AU - Hansen, M. Rosager

AU - Vester-Andersen, M. K.

AU - Eraslan, S.

AU - Prahm, A. P.

AU - Pedersen, N.

AU - Larsen, L.

AU - Jess, T.

AU - Neumann, A.

AU - Haderslev, K. V.

AU - Molazahi, A.

AU - Lødrup, A. B.

AU - Glerup, H.

AU - Oppfeldt, A. M.

AU - Jensen, M. D.

AU - Theede, K.

AU - Kiszka-Kanowitz, M.

AU - Seidelin, J. B.

AU - Burisch, J.

AU - the Danish COVID-IBD Study Group

N1 - Conference code: 17

PY - 2022/1

Y1 - 2022/1

U2 - 10.1093/ecco-jcc/jjab232.807

DO - 10.1093/ecco-jcc/jjab232.807

M3 - Conference abstract in journal

VL - 16

SP - I587-I588

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - Suppl. 1

Y2 - 16 February 2022 through 19 February 2022

ER -